VivoSeq
Other

Ureteral Stent-Related Symptom

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Ureteral Stent-Related Symptom is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

3

clinical trials

Recruiting1 · 33%
Completed1 · 33%
Enrolling by invitation1 · 33%

Clinical Trials

Trial Activity

Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms
Recruiting·—·Phase 3·NCT06803030·189 enrolled
Effect of Antihistamines on Ureteral Stent-Related Symptoms
Completed·—·Phase 2·NCT04726345·78 enrolled
Impact of Ureteral Stent Size on the Management of Post Ureteroscopy Pain: a Randomized Single Blind Trial
Enrolling by invitation·MMayo Clinic·Preclinical·NCT06979583·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)